Trial Profile
Treatment of major depressive disorder with psychotic features with quetiapine monotherapy; quetiapine and citalopram; or haloperidol and citalopram
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary) ; Citalopram; Haloperidol
- Indications Bipolar disorders; Major depressive disorder
- Focus Therapeutic Use
- 09 Jan 2008 Status changed from suspended to discontinued.
- 14 Nov 2005 New trial record.